Eli Lilly
6162 prediction markets tagged with “Eli Lilly”
| # | Market | Platform | Yes | Volume | End Date |
|---|---|---|---|---|---|
| 1 | FDA approves Retatrutide this year? | polymarket | 1¢ | $596K | Jan 1, 2027 |
| 2 | Will Eli Lilly (LLY) Q3 Mounjaro sales be above $10B? | polymarket | 79¢ | $1K | Oct 29 |
| 3 | Will Eli Lilly (LLY) Q3 Zepbound sales be above $5.5B? | polymarket | 38¢ | $1K | Oct 29 |
| 4 | Will Eli Lilly (LLY) Q3 Mounjaro sales be above $13B? | polymarket | 2¢ | $1K | Oct 29 |
| 5 | Will Eli Lilly (LLY) Q3 Mounjaro sales be above $9B? | polymarket | 77¢ | $933 | Oct 29 |
| 6 | Will Eli Lilly (LLY) Q3 Zepbound sales be above $6.5B? | polymarket | 2¢ | $592 | Oct 29 |
| 7 | Will Eli Lilly (LLY) Q3 Zepbound sales be above $5B? | polymarket | 77¢ | $576 | Oct 29 |
| 8 | Will Eli Lilly (LLY) Q3 Zepbound sales be above $6B? | polymarket | 2¢ | $566 | Oct 29 |
| 9 | Will Eli Lilly (LLY) Q3 Mounjaro sales be above $12B? | polymarket | 7¢ | $565 | Oct 29 |
| 10 | Will Eli Lilly (LLY) Q3 Zepbound sales be above $4.5B? | polymarket | 77¢ | $467 | Oct 29 |
| 11 | Will Eli Lilly (LLY) Q3 Mounjaro sales be above $11B? | polymarket | 36¢ | $355 | Oct 29 |